Masazumi Onuki

Switching to tenofovir alafenamide versus continued therapy in chronic hepatitis B patients who were treated with entecavir: A prospective, multicenter, randomized controlled study

A. Masamune, M. Ninomiya, J. Inoue, 2022, Medicine.

Non-Achievement of Alanine Aminotransferase Normalization Associated with the Risk of Hepatocellular Carcinoma during Nucleos(t)ide Analogue Therapies: A Multicenter Retrospective Study

A. Masamune, M. Ninomiya, J. Inoue, 2022, Journal of clinical medicine.

Effectiveness of tacrolimus in a case of immune checkpoint inhibitor-induced hepatotoxicity that was refractory to steroids and mycophenolate mofetil

A. Masamune, M. Ninomiya, J. Inoue, 2023, Clinical Journal of Gastroenterology.

Association of Omega-3 Polyunsaturated Fatty Acids with Sarcopenia in Liver Cirrhosis Patients with Hepatocellular Carcinoma

M. Ninomiya, Akitoshi Sano, M. Tsuruoka, 2024, Journal of clinical and translational hepatology.

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage

K. Abe, M. Ninomiya, M. Fujita, 2023, Scientific reports.

Usefulness of the Fibrosis‐4 index and alanine aminotransferase at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patients

A. Masamune, M. Ninomiya, J. Inoue, 2023, Hepatology research : the official journal of the Japan Society of Hepatology.